Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000020

CEO bought 43,000 shares at an average $0.02 ($827)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

17 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-19 Purchase : show line 1 in the form +2,000 $0.02 $38 21,870,623 D
2019-03-19 Purchase : show line 2 in the form +100 $0.02 $2 21,870,723 D
2019-03-19 Purchase : show line 3 in the form +1,900 $0.02 $36 21,872,623 D
2019-03-19 Purchase : show line 4 in the form +2,000 $0.02 $37 21,874,623 D
2019-03-19 Purchase : show line 5 in the form +10,000 $0.02 $197 21,884,623 D
2019-03-19 Purchase : show line 6 in the form +50 $0.02 $1 21,884,673 D
2019-03-19 Purchase : show line 7 in the form +950 $0.02 $19 21,885,623 D
2019-03-20 Purchase : show line 8 in the form +2,000 $0.02 $39 21,887,623 D
Open-market purchases · 43,000 sh · avg $0.02 · $827
Loading xslF345X03/primary_doc.xml…